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Abstract
Background: Typically, a two-phase (double) sampling strategy is employed when classifications are subject to error and
there is a gold standard (perfect) classifier available. Two-phase sampling involves classifying the entire sample with an
imperfect classifier, and a subset of the sample with the gold-standard.
Methodology/Principal Findings: In this paper we consider an alternative strategy termed reclassification sampling, which
involves classifying individuals using the imperfect classifier more than one time. Estimates of sensitivity, specificity and
prevalence are provided for reclassification sampling, when either one or two binary classifications of each individual using
the imperfect classifier are available. Robustness of estimates and design decisions to model assumptions are considered.
Software is provided to compute estimates and provide advice on the optimal sampling strategy.
Conclusions/Significance: Reclassification sampling is shown to be cost-effective (lower standard error of estimates for the
same cost) for estimating prevalence as compared to two-phase sampling in many practical situations.
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Introduction
Disease prevalence estimates in the presence of an imperfect
classifier (e.g. a diagnostic test with sensitivity and/or specificity
less than one) are biased. The extent of this bias depends on the
true prevalence of the disease and the sensitivity and specificity of
the classifier under consideration. When a ‘‘gold standard’’ (that is
a classifier that has both sensitivity and specificity equal to one) is
available, at least two sampling strategies have been proposed in
order to achieve unbiased prevalence estimates. The first option
(one-phase sampling) involves classifying all individuals in the
sample using the gold standard. However, when the gold standard
is significantly more expensive than an imperfect classifier, two-
phase sampling may be cost-effective [1–6]. Two-phase (or
‘‘double’’) sampling involves classifying all individuals in the
sample with the imperfect mechanism, and then reclassifying a
subset of individuals in the sample with the gold standard.
Essentially, two-phase sampling allows the investigator to estimate
the sensitivity and specificity of the imperfect classifier using
individuals in the sample who have been classified by both the gold
standard and the imperfect classifier. These estimates can then be
used to adjust the prevalence estimate to be unbiased.
An alternative strategy to two-phase sampling is reclassification
sampling. In this design, the entire sample is classified with the
imperfect classifier, followed by a random subset of the sample
classified a second time with the imperfect classifier; generaliza-
tions of reclassification sampling allow for individuals to be
classified any number of times by the imperfect classifier.
Reclassification sampling was first proposed by Sutcliffe in 1965
and soon after by Koch (1969) [7–9]. Since then, several articles
have considered reclassification sampling (see Fujisawa and Izumi
[10] for a brief review), however, these articles consider situations
where some portion of the sample is classified at least three times.
More recently, a hypothesis test for association between two
categorical variables was proposed for reclassification sampling
(applied to Single Nucleotide Polymorphism (SNP) genotype and
disease phenotype data) [11–13]. In that setting one of the variables
is measured perfectly, the other variable is measured imperfectly,
and some fraction r of individuals is reclassified on the imperfectly
measured variable. It was shown that, as long as classification errors
are independent between classifications, only two classifications are
needed in order to carry out the hypothesis test of association.
In this paper we explore practical situations that can provide
estimates of prevalence if individuals are only classified twice.
Further, we provide a cost-effectiveness analysis of reclassification
sampling and compare it with one- and two-phase sampling.
Specifically, we evaluate which sampling strategy is the most cost-
effective in terms of the variance of the prevalence estimate and
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practical situations. Throughout this paper we use the term
‘‘disease prevalence’’ however, the results generalize to any binary
classification procedure that makes independent errors.
Materials and Methods
Sampling strategy
We consider a sampling strategy where a fraction of the original
sample (denoted r) is classified exactly twice using an imperfect classifier.
The remaining fraction of the sample, 1-r, is, therefore, classified
exactly once using the same classifier. One of the goals of this paper is
to find an optimal value for r. We note that all individuals are
classified into one of two mutually exclusive groups, which for con-
venience we call ‘‘Diseased’’ (Group 1) and ‘‘Not Diseased’’ (Group 2).
Error Assumptions
We make a common assumption (e.g. Fujisawa and Izumi [10])
that classification errors have a constant probability for all sample
units. Also, we assume that classification errors are independent,
meaning individuals who were misclassified the first time are as
likely as anyone else to be misclassified the second time they are
classified. For example, consider an individual who happens to be
in the 3% of individuals misclassified the first time they were
classified. If this individual is classified a second time, the
independent error assumption says that this individual still has a
3% chance of being misclassified.
Notation
y=the total number of individuals in the sample that are
classified exactly once.
z=the total number of individuals in the sample that are
classified exactly twice.
N=y+z=the total number of individuals in the sample.
r=z/N=the fraction of the sample that is classified twice, where
0#r#1.
yi=among individuals who are classified exactly once, the
number of individuals who are classified to the i
th group (i=1,2).
zij=the number of individuals classified exactly twice who are
classified to the i
th (i=1,2) group once, and the j
th (j=1,2) group
once. Therefore, if i=j then the individual has been inconsistently
classified.
eij=the probability that an individual who actually belongs in
the i
th category is classified to the j
th category, where for i=1 or
i=2,
P 2
j~1
eij~1.I fi?j then eij is the probability of a classification
error. We let i=1 be ‘‘diseased‘‘ and i=2 be ‘‘not diseased‘‘ and so
e11 represents sensitivity and e22 represents specificity of the test.
pi=the true probability that an individual actually belongs in
the i
th category, where
P 2
i~1
pi~1. Thus, p1 represents the true
population prevalence of the disease.
p
*
i=the proportion of observed individuals in the i
th category
after a single classification.
p
*
ij=the proportion of observed individuals in the i
th group once
and the j
th group once. We note that if there are no classification
errors (i.e. sensitivity=specificity=1), then p*ii=p* i=p i and, for
all i?j, p
*
ij=0.
We also briefly introduce the parameters related to budget and
cost, which are considered in section titled Optimal sampling strategy
for prevalence estimation in the Results.
c=the cost per person of the imperfect classifier,
a=the cost per person for acquisition or enrollment in the study.
cg=the cost per person of the gold standard classifier.
B=the total budget available for sample acquisition and
classification.
Results
Estimating prevalence (p1) using two classifications
System (1) describes the relationship between parameters if
there are only two classifications.
p 11~p1e2
11z(1{p1)(1{e22)
2
p 12~2 p1e11(1{e11)z(1{p1)e22(1{e22) ðÞ
p 22~p1(1{e11)
2z(1{p1)e2
22
ð1Þ
These equations are not independent due to the constraint
p 11zp 12zp 22~1 and, hence, the system is not uniquely
solvable. To resolve that problem, one can either reduce the
number of parameters or add an equation to the system. Fujisawa
and Izumi [10], as well as Sutcliffe [6,7], introduce additional
equations by requiring at least three classifications in order to
estimate prevalence, sensitivity and specificity. It is possible,
however, to reduce the number of parameters in the system with
an alternative constraint and avoid a third classification. We
assume that there is a relationship between sensitivity and
specificity. For example, we might assume that e22 is 80% of e11,
or, in the simplest case, that e22=e11. In this paper we consider the
following functional relationship, e22=he 11, where h can be any
positive number as long as 0#e22#1. In this paper we consider the
robustness of estimation and, ultimately, optimal sampling strategy
decisions if the value of h is incorrect.
If we assume that h is known, we can rewrite p1, e11 and e22 as
functions of p*11 and p*12. (See Text S1 for details).
p1~
p 11{(1{he11)
2
e2
11{(1{he11)
2 ð2Þ
0~e3
11 {h
2{h
  
z
e2
11 0:5 {p  12 zh
2p 12
  
zp  11 h
2{p  11 z1z2h
  
z
e11(p  11 {1{hp  11 {hp  12 )z0:5p 12
ð3Þ
Equation (3) can be solved using the cubic formula. Since p*ij
(i,j=1,2)i n( 1) have a multinomial distribution, we know that their
MLE’s are the observed counts in each cell of the multinomial
distribution divided by the sample size (e.g., ^ p p 12~
z12
z
, where ^ p p 12
is the MLE of p*12). The system of equations (2), (3) can be
significantly simplified if we consider h=1. In this case, by the
invariance property of MLE’s [14], we get
^ e e11~^ e e22~
1z
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1{
2z12
z
r
2
ð4Þ
^ p p1~
z11
z
{(1{^ e e11)
2
2^ e e11{1
(r)z
y1
y
{(1{^ e e11)
2^ e e11{1
(1{r) ð5Þ
Where ^ e e11,^ e e22 and ^ p p1 are the MLE’s of e11, e22, and p1,
respectively. Note that equation (5) combines information from
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(See Text S1 for details). Later, in the section titled Robustness of the
model assumptions (case h?1), we consider the robustness of this
approach for other values of h.
In order to find the expected value and variance of the
prevalence estimate (^ p p1) given in (5) we use a first order Taylor
series approach as described in Casella and Berger [14]. The
Taylor series approach says for a set of random variables
~ T T~ T1,:::,Tk) ðÞ with means ~ h h~ h1,:::,hk) ðÞ that for any differen-
tiable function g(~ T T), Eg (~ T T)
hi
&g ~ h h
  
. In our case, the functions
used for g(~ T T) are equations shown in Text S1, and thus we have
the result that E(^ p p1)&p1, E(^ e e11)&e11 and E(^ e e22)&e22. We can
use the same Taylor series approach to find the variance of ^ p p1 as
Var(^ p p1)&
1
N
r
p 11(1{p 11)z0:25p 12(1{p 12){p 1(1{p 1){p 11p 12
(2e11{1)
2
  
z
1
r
p 12(1{p 12)(1{2p 1)
2
4(2e11{1)
6
 !
z
1
(2e11{1)
2
(p 11)(p 12)(1{2p 1)
(2e11{1)
2 {
p 12(1{p 12)(1{2p 1)
2(2e11{1)
2
zp 1(1{p 1)
0
B @
1
C A
0
B B B B B B B B B B B B @
1
C C C C C C C C C C C C A
ð6Þ
Text S2 provides details on how the variance formula is derived
and also provides the variance of the sensitivity estimate Var(^ e e11):
A simulation study using R [15] was conducted in order to
investigate the quality of the Taylor series approximation. To
conduct the simulation, seven values of disease prevalence (0.001,
0.01, 0.05, 0.10, 0.25, 0.40 and 0.50), five values of sensitivity
(equal to specificity; 0.80, 0.90, 0.95, 0.99, 0.999), ten values of the
reclassification rate r (0.01, 0.05, 0.10, 0.25, 0.50, 0.75, 0.90, 0.95,
0.99, 1.0), and three values for the total sample size n (=z+y; 500,
1000 and 5000) were selected. We considered all possible
combinations of these parameters (76561063=1050), except
for 105 settings where z=r*n,50, since estimates with less than 50
reclassified individuals can be unstable. For each of the 945 (1050-
105) combinations examined, 2000 samples were simulated.
Ninety-two percent (868/945) of the cases examined had a
simulated expected value within 10
23 of the true sensitivity with
100% of the cases (945/945) within 10
22. Similarly, 79% (749/945)
of the cases examined had a simulated expected value within 10
23 of
thetrue prevalencewith98%(922/945)ofthecaseswithin10
22.T he
most biased estimates occurred when prevalence was very low (e.g.,
prevalence#0.01) and when sensitivity/specificity was lower (e.g.,
sensitivity#0.90). In these cases, the tendency was to underestimate
the sensitivity/specificity, which results in an overestimate of the
prevalence. For example, the most biased sensitivity estimate was
when the true sensitivity was 80%, but the estimate was 79.4%, which
occurred when n=5000 and r=0.01, for prevalence 10%. Addi-
tionally, the most biased prevalence estimate was when prevalence
was 0.1%, sensitivity was 80%, r=0.05 and n=1000, when the
estimated prevalence was 3.0%.
To ease in interpretation, and to allow for comparison across
different sample sizes, variance differences between the simulated
and theoretical variance are reported multiplied by a factor of 1/n.
Eighty-five percent (799/945) of the cases examined have a
difference between theoretical and simulated variance of less than
10
21(1/n) for sensitivity with 96% (911/945) less than 1/n. Also,
65% (615/945) of the cases have a difference between theoretical
and simulated variance of less than 10
21(1/n) for prevalence with
87% (826/945) having a difference in variances less than 1/n.
Similar to the results for expected value, the most biased estimates
occurred when prevalence was very low (e.g., prevalence#0.01)
and when sensitivity/specificity was lower (e.g., sensitivity#0.90).
In these cases, the simulated variance tended to be more than
theoretical (predicted) variance for sensitivity, and less than the
theoretical (predicted) variance for prevalence. For example, the
most biased variance estimate for sensitivity occurred for sensitivity
80%, prevalence 10%, r=5%, n=1000, when the simulated
variance was 0.0004 larger than the theoretical (predicted)
variance. Additionally, the most biased estimate of the variance
for prevalence occurred when the prevalence was 0.1%, sensitivity
was 80%, r=0.01 and n=5000, when the simulated variance was
0.007 less than the theoretical (predicted) variance.
As anticipated, the Taylor Series approximation approach
provides reasonable estimates, except in situations where the most
extreme values of the parameters occur. Having established that
the estimates shown in (4) and (5) are approximately unbiased with
known variance, confidence intervals are easily obtained using the
delta method [14]. Details of a simulation study which verified
proper coverage probabilities for the confidence intervals are not
shown.
Optimal sampling strategy for prevalence estimation
We now discuss how to optimize reclassification sampling, and
then compare an optimally designed reclassification sampling
study to the traditional one- and two-phase sampling methods.
In order to optimally design a reclassification sampling study we
need to establish the value of the reclassification rate r, 0,r#1,s o
that the variance of the ^ p p1 estimator (given in (6)) is minimized for
a fixed budget B. The available budget is used to cover costs of
sample acquisition (Na), as well as initial and subsequent
classification (2cNr+N(12r)c), leading to equation (7):
B~Nr(az2c)zN(1{r)(azc) ð7Þ
Based on equations (6) and (7) we find the variance of the
prevalence estimate as a function of r. We can then find the
optimal value of r by finding the minimum variance of the
prevalence estimate Var(^ p p1) for 0,r#1.
We examined six different values of p1 (0.01, 0.05, 0.10, 0.25,
0.40 and 0.50), seven different values of e11 (0.999, 0.99, 0.98,
0.95, 0.90, 0.85, 0.80), nine different values of c (0.001, 0.01, 0.05,
0.10, 0.20, 0.50, 1, 2, and 5), and two different values of a (0 and 1;
representing samples that have already been obtained (a=0), or
samples that have acquisition cost that can be expressed relative to
the classification cost, c (a=1) yielding 756 total combinations.
While the budget (and hence sample size) does affect the value of
the variance, it does not change the optimal value of r (see Text S3
for details).
Overall, 379 of the 756 optimal values of r were at 1.0, and 109
times the optimal value of r was at 0.01. We used r=0.01 as the
minimum value of r. The remaining 256 cases yielded an optimal r
between 0.01 and 1. In 100 of the 109 times that the optimal value
was at 0.01, the prevalence was 50% (the other nine times was
when prevalence was at 40%). In contrast, when the optimal
reclassification rate was at r=1, prevalence tended to be lower,
acquisition costs were present, classification costs were low, and
sensitivity was lower.
As is described in the introduction, previous work by McNamee
[3] compared the cost effectiveness of two-phase (double) sampling
to one-phase sampling. Text S4 uses our notation to give equations
for the variance of one and two-phase sampling.
ð6Þ
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sampling we first establish which of one- or two-phase sampling is
the most cost-effective by minimizing the two variances given in
Text S4 equations (S.4.1) and (S.4.2). Then we compare the
variance obtained from an optimally designed reclassification
study to the minimum of the other two. Tables 1, 2, 3 how the ratio
of SEtwophase=SEreclassification for the prevalence estimate. In all
cases where the ratio is greater then 1, reclassification sampling
provides a smaller standard error for the same budget. The cost
ratio is the ratio of the cost of the gold standard (cg) to the
classification cost for the cheap classifier (c). All values shown in
Tables 1, 2, 3 assume an acquisition cost (a) of 0, though values for
a=1 follow a similar pattern (detailed results not shown).
Additionally, as explained in Text S4, values in Tables 1, 2, 3 are
independent of budget/sample size considerations.
Tables 1, 2, 3 present values for a variety of prevalence,
sensitivity and cost ratio values. We note that in many cases,
reclassification sampling provides a substantial reduction in the
standard error of the prevalence estimate as compared to one or
two-phase sampling. As shown in Tables 1, 2, 3, reclassification
becomes increasingly effective as the cost ratio increases (that is,
the gold standard becomes more expensive as compared to the
imperfect classifier). Also, reclassification sampling provides
increasing advantages as the prevalence increases.
Robustness of the model assumptions (case h?1)
It is of interest to know how robust the estimates provided
earlier ((4) and (5)) are to violations of the assumption that h=1.
To answer this question we conducted a simulation study to
evaluate the bias in cases where sensitivity and specificity are not
equal. We extended an earlier simulation study and examined
seven values of disease prevalence (0.001, 0.01, 0.05, 0.10, 0.25,
0.40 and 0.50), five values of sensitivity (0.80, 0.90, 0.95, 0.99,
0.999), five values of specificity (0.80, 0.90, 0.95, 0.99, 0.999), ten
values of the reclassification rate r (0, 0.01, 0.05, 0.10, 0.25, 0.50,
0.75, 0.90, 0.95, 0.99, 1.0), and three values for the total sample
size n (=z+y; 500, 1000 and 5000). For each combination of
prevalence, sensitivity, specificity, reclassification rate and sample
size (4725, since we eliminated 525 combinations where
z=r*n,50), 2000 samples were simulated.
In order to investigate robustness, we started by evaluating the
extent of bias for prevalence estimates in cases where
0.95#h#1.05, but h?1. In 73.5% (695/945) of cases, the bias
for the prevalence estimate was within 1% of the true prevalence,
with all bias within 3% of the true prevalence estimate. However,
in contrast to our results earlier for cases where h=1, the largest
bias occurred when the prevalence was large. For example, the
largest bias occurred when prevalence was 50%, sensitivity was
99.9%, specificity was 95%, n=500, r=0.25, and the average
observed prevalence was 53.7%.
As h deviated more and more from one, the bias increased
rather dramatically, The maximum bias observed was 12.6%
(estimated prevalence of 52.6%), when the observed prevalence
was 40%, the sensitivity was 0.999, the specificity was 80%,
r=5%, and n=1000. Thus, estimates of prevalence are relatively
robust in situations where the sensitivity and specificity are not
equal (h?1), as long as the extent of the inequality keeps
0.95#h#1.05.
In the previous section we evaluated the bias of the prevalence
estimates to misspecifications of h. In this section we consider the
robustness of the ratio of standard errors comparing two-phase to
reclassification sampling (presented in Tables 1, 2, 3)t o
misspecifications of h. To do this we compare the simulated
standard error of the prevalence estimate to the theoretical
standard error of the prevalence estimate (for a value of h equal to
1). We recommend a conservative approach where a researcher
should use the value of specificity for both parameters e11 and e22
in the theoretical computation as long as the prevalence is less than
50% and when prevalence is more than 50% use the sensitivity as
a value for e11 and e22. For example, if sensitivity=90%,
specificity=95% and prevalence is less than 50%, the researcher
should use e11=e22=0.95 in the theoretical computation. Using
this rule in the theoretical computation yields theoretical ratios of
Table 1. Ratios of Standard Errors (SEtwophase=SEreclassification)
when Sensitivity=Specificity=0.99.
Cost Ratio (cg/c)
Prevalence Optimal r
a 5 25 50 100 500
0.01 1 0.88 1.19 1.47 1.87 3.59
0.05 0.32 1.04 1.46 1.78 2.22 4.11
0.10 0.20 1.15 1.61 1.95 2.43 4.47
0.25 0.08 1.29 1.78 2.16 2.69 4.92
0.40 0.03 1.36 1.88 2.27 2.83 5.17
0.50 0.01 1.39 1.93 2.33 2.90 5.30
aThe optimal reclassification rate for reclassification sampling.
doi:10.1371/journal.pone.0032058.t001
Table 2. Ratios of Standard Errors (SEtwophase=SEreclassification)
when Sensitivity=Specificity=0.95.
Cost Ratio (cg/c)
Prevalence Optimal r
a 5 25 50 100 500
0.01 1 0.94 1.54 2.04 2.78 5.94
0.05 1 1.09 1.86 2.45 3.28 6.79
0.10 0.74 1.16 1.96 2.56 3.40 6.98
0.25 0.21 1.41 2.34 3.03 4.01 8.13
0.40 0.07 1.58 2.60 3.37 4.45 9.01
0.50 0.01 1.68 2.76 3.57 4.71 9.54
aThe optimal reclassification rate for reclassification sampling.
doi:10.1371/journal.pone.0032058.t002
Table 3. Ratios of Standard Errors (SEtwophase=SEreclassification)
when Sensitivity=Specificity=0.80.
Cost Ratio (cg/c)
Prevalence Optimal r
a 5 25 50 100 500
0.01 1 0.33 0.65 0.90 1.26 2.78
0.05 1 0.68 1.33 1.84 2.56 5.61
0.10 1 0.87
b 1.72 2.36 3.28 7.13
0.25 1 1.08
b 2.19 2.99 4.12 8.88
0.40 0.22 1.19
b 2.44 3.33 4.57 9.84
0.50 0.01 1.34
b 2.75 3.74 5.14 11.06
aThe optimal reclassification rate for reclassification sampling.
bCompared to one-phase sampling, because in these cases, one-phase sampling
provides estimates with smaller standard errors then with two-phase sampling.
doi:10.1371/journal.pone.0032058.t003
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Tables 1, 2, 3 (meaning (Observed Ratio-Theoretical Ratio)/
Theoretical Ratio is no more than 0.1) in 98.6% of cases examined
as long as the expected values of z11 and z12 are both at least 5 and
0.90#h#1.10. Thus, we have shown that the ratios of standard
errors in Tables 1, 2, 3are relatively robust to situations where the
sensitivity and specificity are not equal.
Application of reclassification sampling
Fujisawa and Izumi [10] provide prevalence, sensitivity, and
specificity estimates based on repeated classifications of an
individual’s blood type according to the MNSs blood typing
system. As a proof of concept of the methods proposed earlier for
computing estimates and confidence intervals for sensitivity,
specificity and prevalence we apply the estimation procedure to
data from Fujisawa and Izumi [10] on individuals only classified
two times. Results are shown in Table 4. These estimates were
computed using software available at (http://www.dordt.edu/
statgen and following the links to software).
Our estimates of prevalence and sensitivity/specificity are
within the confidence intervals provided by Fujisawa and Izumi,
except for the specificity confidence interval provided by Fujisawa
and Izumi for Hiroshima (0.957, 0.993), which does not include
our point estimate of 0.998.
Discussion
In this paper we evaluated reclassification sampling, considering
the situation where some fraction of the sample is classified by the
same imperfect method two times. We demonstrated how to
estimate prevalence and sensitivity/specificity for reclassification
sampling. We established that reclassification sampling is cost-
effective in many cases when compared to one and two-phase
sampling. We also demonstrated the extent of robustness of
estimates and the sampling strategy decision to violations of model
assumptions.
The fact that reclassification sampling is more cost-effective
than one- and two-phase sampling to estimate prevalence may not
be intuitive. However, consider the following example. Let’s
assume that a diagnostic test with sensitivity and specificity of 95%
is available for $1.00 per application, and a gold-standard
diagnostic test is available for $100. Table 2 shows that if the
prevalence of the disease in the population is 1% then recla-
ssification sampling is approximately 2.78 times more cost-effective
than two-phase sampling. Using optimality criterion for two-phase
sampling, a researcher will use the gold standard on approximately
11.5% of the total sample, n. For a budget of $10,000 this means
that a researcher will be able to have approximately 800 people in
the study. An optimally designed reclassification study uses an r=1
(everyone gets reclassified). Thus, the reclassification study will
have 5,000 people in the study. In essence, having more than 6
times as many people in the reclassification study outweighs the
perfect data obtained from the gold-standard in the two-phase
sample.
The assumption of independent errors for the reclassification
sampling strategy is crucial to its utility. If errors are not
independent then reclassifying individuals does not ‘‘clean-up’’
the mistakes—instead misclassifying individuals time after time.
There are likely many applications where the independent error
assumption is legitimate. Tintle et al. [16] provide data which
suggests that Single Nucleotide Polymorphism (SNP) genotyping
errors appear to follow an independent misclassification pattern.
Additionally, Fujisawa and Izumi [10] argue that the independent
error assumption may be legitimate for blood typing data.
Conceivably there are many other classification processes
(diagnostic tests, etc.) where errors are independent and for which
reclassification sampling provides an alternative, and in many
cases more efficient, sampling strategy.
It is interesting to consider cases when the optimal strategy
requires the reclassification of the entire sample (r=1). It may
suggest that increasing the number of reclassifications may provide
further reduction in the variance estimate. We considered cases of
multiple reclassifications when a separate optimal rate can be
found for each stage. More specifically let ri be the percentage of
the sample that is reclassified i times. We considered the optimal
selection of a vector of rates (r1,r2,:::,rk) that minimizes Var(^ p p1).
Note that having multiple classifications does not rely on
knowledge of h. However, a preliminary analysis of this design,
using the EM-algorithm, did not reveal any substantial gains in the
cost-effectiveness. In other words, three or more classifications
provided little increase in efficiency as compared to two
classifications.
We note that, in some settings, known values of the sensitivity
and specificity are available. In these cases neither two-phase
sampling nor reclassification sampling is necessary because
prevalence estimates can be made unbiased by incorporating
known sensitivity/specificity estimates into the estimation. The
purpose of both two-phase sampling and reclassification sampling
is to provide empirical estimates of sensitivity/specificity which can
then be used to adjust prevalence estimates to be unbiased.
To this point, two-phase (double) sampling has been the
primary alternative sampling strategy for investigators handling
data subject to misclassification errors. McNamee [3] has shown
that for prevalence estimation two-phase sampling can be cost-
effective. However, reclassification can provide relatively large
improvements in precision when compared to two-phase sampling
with realistic and robust assumptions on sensitivity and specificity.
Precision gains increase as the relative cost of the gold standard
increases and as the prevalence increases. Software is provided to
assist investigators in making a decision about which sampling
strategy is most cost-effective based on their sampling costs,
anticipated sensitivity/specificity and prevalence.
When two-phase sampling was originally proposed, the gold-
standard classifier was used on a random subsample of all
individuals. However, Cochran [17] and more recently McNamee
Table 4. Prevalence estimation using reclassified data from Fujisawa and Izumi (2000).
Number of subjects testing positive for the antigen M
City z11 z12 z22 n=z ^ e e11~^ e e22 (95% CI) ^ p p1 (95% CI)
Hiroshima 1918 8 419 2345 0.998 (0.997, 0.999) 0.821 (0.805, 0.836)
Nagasaki 958 13 257 1228 0.994 (0.992, 0.998) 0.788 (0.766, 0.811)
doi:10.1371/journal.pone.0032058.t004
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PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e32058[3] demonstrated how using the gold standard at different rates in
different groups provides an even more optimal version of two-
phase sampling. Conceivably, a similar concept could be applied
to reclassification sampling. Specifically, rather than reclassifying a
random subsample of all individuals, reclassify r1 individuals who
are diagnosed as ‘‘diseased’’ the first time, and reclassify r2
individuals who are diagnosed as ‘‘not diseased’’ the first time,
where r1 is not necessarily equal to r2. Thus ‘‘conditional
reclassification sampling’’ may provide an even further optimized
reclassification sampling strategy. Preliminary simulation studies
suggest this to be the case.
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